FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164409991> ?p ?o ?g. }

• W3164409991 endingPage "2114" @default.
• W3164409991 startingPage "2102" @default.
• W3164409991 abstract "Article Tools REVIEW ARTICLES Caring for Older Adults With Cancer Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.21.00242 Journal of Clinical Oncology - published online before print May 27, 2021 PMID: 34043442 Advances in Management for Older Adults With Hematologic Malignancies Ashley E. Rosko , MD1xAshley E. RoskoSearch for articles by this author; Raul Cordoba , MD, PhD2xRaul CordobaSearch for articles by this author; Gregory Abel , MD, MPH3xGregory AbelSearch for articles by this author; Andrew Artz , MD4xAndrew ArtzSearch for articles by this author; Kah Poh Loh , MBBCh, BAO5xKah Poh LohSearch for articles by this author; and Heidi D. Klepin , MD, MS6xHeidi D. KlepinSearch for articles by this author Show More 1Division of Hematology, The Ohio State University, Columbus, OH2Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain3Leukemia Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA5James P. Wilmot Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY6Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC https://doi.org/10.1200/JCO.21.00242 First Page Full Text PDF Figures and Tables © 2021 by American Society of Clinical OncologyCONTEXTKey ObjectiveHow do advances in therapeutics and geriatric assessment (GA) strategies inform personalized management for older adults with hematologic malignancies?Knowledge GeneratedNovel therapeutics, targeted therapies, and maintenance strategies are improving outcomes for older adults including those who have functional impairments and competing comorbid conditions. GA and frailty measures are predictive of treatment tolerance and outcomes across various hematologic malignancies.RelevanceIntegration of GA measures into practice can inform shared treatment decisions and guide management of identified vulnerabilities to enhance therapeutic benefit and quality of life.SUPPORTH.D.K. was supported by the National Institute on Aging (R33AG059206).AUTHOR CONTRIBUTIONSConception and design: Ashley E. Rosko, Raul Cordoba, Gregory Abel, Andrew Artz, Heidi D. KlepinProvision of study materials or patients: Kah Poh LohCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTAdvances in Management for Older Adults With Hematologic MalignanciesThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Ashley E. RoskoConsulting or Advisory Role: Association of Community Cancer Centers (ACCC), MedscapeTravel, Accommodations, Expenses: Jazz PharmaceuticalsRaul CordobaConsulting or Advisory Role: Takeda, Kyowa-Kirin, Kite/Gilead, Incyte, Janssen, Celgene/Bristol-Myers SquibbSpeakers' Bureau: Abbvie, AstraZeneca, RocheResearch Funding: PfizerTravel, Accommodations, Expenses: Janssen, Abbvie, RocheAndrew ArtzEmployment: Radiology PartnersStock and Other Ownership Interests: Radiology PartnersConsulting or Advisory Role: BiogenOpen Payments Link: https://openpaymentsdata.cms.gov/physician/331072Kah Poh LohConsulting or Advisory Role: Pfizer, Seattle GeneticsHeidi D. KlepinConsulting or Advisory Role: Genentech, PfizerPatents, Royalties, Other Intellectual Property: UpToDate contributorUncompensated Relationships: GenentechNo other potential conflicts of interest were reported." @default.
• W3164409991 created "2021-06-07" @default.
• W3164409991 creator A5019488668 @default.
• W3164409991 creator A5029311650 @default.
• W3164409991 creator A5044575293 @default.
• W3164409991 creator A5045867757 @default.
• W3164409991 creator A5060454577 @default.
• W3164409991 creator A5091710463 @default.
• W3164409991 date "2021-07-01" @default.
• W3164409991 modified "2023-10-06" @default.
• W3164409991 title "Advances in Management for Older Adults With Hematologic Malignancies" @default.
• W3164409991 cites W1644085412 @default.
• W3164409991 cites W1984322159 @default.
• W3164409991 cites W2007584552 @default.
• W3164409991 cites W2013923593 @default.
• W3164409991 cites W2028311823 @default.
• W3164409991 cites W2048483323 @default.
• W3164409991 cites W2051639896 @default.
• W3164409991 cites W2057672178 @default.
• W3164409991 cites W2065464763 @default.
• W3164409991 cites W2065738117 @default.
• W3164409991 cites W2081279521 @default.
• W3164409991 cites W2106292925 @default.
• W3164409991 cites W2109065151 @default.
• W3164409991 cites W2114396320 @default.
• W3164409991 cites W2124110638 @default.
• W3164409991 cites W2131424155 @default.
• W3164409991 cites W2136621779 @default.
• W3164409991 cites W2141105112 @default.
• W3164409991 cites W2144755223 @default.
• W3164409991 cites W2145233309 @default.
• W3164409991 cites W2149146117 @default.
• W3164409991 cites W2164186760 @default.
• W3164409991 cites W2171757275 @default.
• W3164409991 cites W2298793090 @default.
• W3164409991 cites W2310134410 @default.
• W3164409991 cites W2519141169 @default.
• W3164409991 cites W2563063147 @default.
• W3164409991 cites W2567188480 @default.
• W3164409991 cites W2584941439 @default.
• W3164409991 cites W2604776612 @default.
• W3164409991 cites W2615984387 @default.
• W3164409991 cites W2621741324 @default.
• W3164409991 cites W2623089849 @default.
• W3164409991 cites W2715749014 @default.
• W3164409991 cites W2733429355 @default.
• W3164409991 cites W2773804840 @default.
• W3164409991 cites W2787801189 @default.
• W3164409991 cites W2789878780 @default.
• W3164409991 cites W2799290306 @default.
• W3164409991 cites W2799900329 @default.
• W3164409991 cites W2801129665 @default.
• W3164409991 cites W2805411213 @default.
• W3164409991 cites W2806682325 @default.
• W3164409991 cites W2809084663 @default.
• W3164409991 cites W2871372177 @default.
• W3164409991 cites W2883399820 @default.
• W3164409991 cites W2902959791 @default.
• W3164409991 cites W2903062212 @default.
• W3164409991 cites W2905344869 @default.
• W3164409991 cites W2909552152 @default.
• W3164409991 cites W2919604435 @default.
• W3164409991 cites W2919842046 @default.
• W3164409991 cites W2923466167 @default.
• W3164409991 cites W2924141612 @default.
• W3164409991 cites W2940895881 @default.
• W3164409991 cites W2944229406 @default.
• W3164409991 cites W2946564370 @default.
• W3164409991 cites W2947822050 @default.
• W3164409991 cites W2947874495 @default.
• W3164409991 cites W2948871379 @default.
• W3164409991 cites W2949283591 @default.
• W3164409991 cites W2962478573 @default.
• W3164409991 cites W2969287051 @default.
• W3164409991 cites W2969709096 @default.
• W3164409991 cites W2970922094 @default.
• W3164409991 cites W2971500428 @default.
• W3164409991 cites W2971579301 @default.
• W3164409991 cites W2976907750 @default.
• W3164409991 cites W2977341944 @default.
• W3164409991 cites W2981890284 @default.
• W3164409991 cites W2983326001 @default.
• W3164409991 cites W2983381086 @default.
• W3164409991 cites W2984456286 @default.
• W3164409991 cites W2984927918 @default.
• W3164409991 cites W2987293506 @default.
• W3164409991 cites W2990635370 @default.
• W3164409991 cites W2990836214 @default.
• W3164409991 cites W2991333687 @default.
• W3164409991 cites W2993594890 @default.
• W3164409991 cites W2995123606 @default.
• W3164409991 cites W2996752315 @default.
• W3164409991 cites W2998901800 @default.
• W3164409991 cites W3007726400 @default.
• W3164409991 cites W3008659445 @default.
• W3164409991 cites W3011327279 @default.
• W3164409991 cites W3014583893 @default.
• W3164409991 cites W3015328784 @default.

• next